[183 Pages Report] The Radiotherapy Market size was estimated at USD 6.64 billion in 2023 and expected to reach USD 7.03 billion in 2024, at a CAGR 6.04% to reach USD 10.01 billion by 2030.
Radiotherapy comprises businesses in the medical and healthcare sectors that harness radiation as a mode of treatment, typically for cancer and some non-malignant conditions. It involves deploying high-energy radiation, such as X-rays, gamma rays, and charged particles, primarily destroying cancerous cells, minimizing their growth, and reducing symptoms in palliative cases. The growing adoption of radiotherapy procedures for cancer treatment and rising preference for minimally invasive procedures influence the development of radiotherapy. In contrast, high treatment costs, limited availability of trained professionals, and risks associated with radiation exposure are restricting the utilization of radiotherapy. However, several vendors are working and investing in R&D to overcome these issues. Furthermore, technological advancements and improvements in radiotherapy devices and the introduction of robotic radiotherapy systems for cancer treatment are opportunities for businesses to create and market cutting-edge devices.
Regional Insights
The adoption of radiotherapy in the Americas is driven by various factors, primarily increasing cancer prevalence rates and a general preference for non-invasive treatment methods. Advanced technologies such as 3D conformal radiotherapy (3D CRT) and intensity-modulated radiotherapy (IMRT) contribute to this market’s growth. Simultaneously, government initiatives focusing on cancer prevention and control are a significant factor behind this market’s expansion. EMEA region has an increasing need for radiotherapy due to rising cancer incidents. With diverse cancer cases observed across the region, radiotherapy becomes a preferred treatment solution, offering targeted and efficient treatment outcomes. Regulatory approvals for innovative radiotherapy devices, the proliferation of cancer research, and robust healthcare frameworks further bolster the market. The APAC region is witnessing a rapid expansion in the radiotherapy market driven by the escalating burden of cancer. Several countries have high cancer rates, fueling the need for effective treatment modalities, including radiotherapy. The sector’s growth is amplified by increasing awareness about early diagnosis, improved access to cancer treatments, and technological advancements within this domain. APAC’s emerging economies are also investing heavily in healthcare infrastructure, which further propels the adoption of radiotherapy.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Radiotherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiotherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Charles River Laboratories International, Inc., Elekta AB, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., IBA Dosimetry GmbH, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., PerkinElmer, Inc., Qfix, Quanterix Corporation, Radiology Oncology Systems, Siemens AG, Varian Medical Systems, Inc., ViewRay Technologies, Inc., and ZEISS Group.
Market Segmentation & Coverage
This research report categorizes the Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Hardware
- Software & Service
- Type
- External Beam Radiotherapy/Teletherapy
- Conventional Cabalt-60 Teletherapy Units
- Linear Accelerators
- Conventional Linear Accelerators
- CyberKnife TomoTherapy
- Gamma Knife
- MRI LINAC
- Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
- Particle Therapy Systems
- Cyclotrons
- Synchrocyclotron
- Synchrotrons
- Internal Beam Radiotherapy/Brachytherapy
- Afterloaders
- Applicators
- IORT Systems
- Seeds
- Systemic Radiotherapy
- lobenguane (l-131)
- Rhenium-186
- Samarium-153
- External Beam Radiotherapy/Teletherapy
- Procedure
- External Beam Radiotherapy
- 3D Conformal Radiotherapy
- Image-Guided Radiotherapy
- Intensity-Modulated Radiotherapy
- Particle Therapy
- Stereotactic Therapy
- Instillation Radiotherapy
- Internal Beam Radiotherapy or Brachytherapy
- High-Dose-Rate Brachytherapy
- Low-Dose-Rate Brachytherapy
- Pulsed-Dose-Rate Brachytherapy
- Intravenous Radiotherapy
- Oral Radiotherapy
- Systemic Radiotherapy
- External Beam Radiotherapy
- Application
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Gynecological Cancer
- Head & Neck Cancer
- Lung Cancer
- Penile Cancer
- Prostate Cancer
- End-User
- Hospitals
- Independent Radiotherapy Centers
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Radiotherapy Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiotherapy Market?
- What are the technology trends and regulatory frameworks in the Radiotherapy Market?
- What is the market share of the leading vendors in the Radiotherapy Market?
- Which modes and strategic moves are suitable for entering the Radiotherapy Market?
US $
Euro €
GBP £